Drugs and Endogenous Factors as Protagonists in Neurogenic Stimulation

Stem Cell Rev Rep. 2022 Dec;18(8):2852-2871. doi: 10.1007/s12015-022-10423-y. Epub 2022 Aug 12.

Abstract

Neurogenesis is a biological process characterized by new neurons formation from stem cells. For decades, it was believed that neurons only multiplied during development and in the postnatal period but the discovery of neural stem cells (NSCs) in mature brain promoted a revolution in neuroscience field. In mammals, neurogenesis consists of migration, differentiation, maturation, as well as functional integration of newborn cells into the pre-existing neuronal circuit. Actually, NSC density drops significantly after the first stages of development, however in specific places in the brain, called neurogenic niches, some of these cells retain their ability to generate new neurons and glial cells in adulthood. The subgranular (SGZ), and the subventricular zones (SVZ) are examples of regions where the neurogenesis process occurs in the mature brain. There, the potential of NSCs to produce new neurons has been explored by new advanced methodologies and in neuroscience for the treatment of brain damage and/or degeneration. Based on that, this review highlights endogenous factors and drugs capable of stimulating neurogenesis, as well as the perspectives for the use of NSCs for neurological and neurodegenerative diseases.

Keywords: Bone morphogenetic proteins; Cell differentiation; Neural stem cells; Neurogenesis; Neurotrophins, Notch; Sonic hedgehog; Wnt wingless-related.

Publication types

  • Review

MeSH terms

  • Adult
  • Animals
  • Humans
  • Infant, Newborn
  • Lateral Ventricles
  • Mammals
  • Neural Stem Cells*
  • Neurogenesis* / physiology
  • Neuroglia
  • Neurons